A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3)

Bone

Volumn 67, Issue , 2014, Pages 156-165

  Liu, Ting ^a   Qin, Ai Ping ^b   Liao, Bin ^b   Shao, Hui Ge ^c   Guo, Li Juan ^d   Xie, Gen Qing ^c   Yang, Li ^b,d   Jiang, Tie Jian ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Province Geriatric Hospital   (China)

^c CHANGSHA CENTRAL HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bone; Differentiation; MicroRNA; Osteoclast; PIAS3

Indexed keywords

ANTAGOMIR; COLONY STIMULATING FACTOR 1; MICRORNA; MICRORNA 9718; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT3; UNCLASSIFIED DRUG; PIAS3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; FEMALE; FEMUR; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LUCIFERASE ASSAY; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; PREDICTION; PROTEIN EXPRESSION; PROTEIN TARGETING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; OSTEOCLAST; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICRORNAS; OSTEOCLASTS; PROTEIN INHIBITORS OF ACTIVATED STAT; RANK LIGAND;

EID: 84904901187     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.07.004     Document Type: Article

References (43)

1. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
2. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
3. Felix R., Cecchini M.G., Hofstetter W., Elford P.R., Stutzer A., Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 1990, 5:781-789.
4. Wada T., Nakashima T., Hiroshi N., Penninger J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006, 12:17-25.
5. Nakashima T., Hayashi M., Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Cell 2012, 23:582-590.
6. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005, 33:2697-2706.
7. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
8. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
9. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
10. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
11. Huppi K., Volfovsky N., Mackiewicz M., Runfola T., Jones T.L., Martin S.E., et al. MicroRNAs and genomic instability. Semin Cancer Biol 2007, 17:65-73.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
13. Wang B., Love T.M., Call M.E., Doench J.G., Novina C.D. Recapitulation of short RNA-directed translational gene silencing in vitro. Mol Cell 2006, 22:553-560.
14. Rossi M., Pitari M.R., Amodio N., Di Martino M.T., Conforti F., Leone E., et al. miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol 2013, 228:1506-1515.
15. Sugatani T., Hruska K.A. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 2009, 284:4667-4678.
16. Cheng P., Chen C., He H.B., Hu R., Zhou H.D., Xie H., et al. MiR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 2013, 28:1180-1190.
17. Zhang J., Zhao H., Chen J., Xia B., Jin Y., Wei W., et al. Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett 2012, 586:3255-3262.
18. Chikazu D., Hakeda Y., Ogata N., Nemoto K., Itabashi A., Takato T., et al. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 2000, 275:31444-31450.
19. Ro S., Park C., Song R., Nguyen D., Jin J., Sanders K.M., et al. Cloning and expression profiling of testis-expressed piRNA-like RNAs. RNA 2007, 13:1693-1702.
20. Ambros V., Bartel B., Bartel D.P., Burge C.B., Carrington J.C., Chen X., et al. A uniform system for microRNA annotation. RNA 2003, 9:277-279.
21. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004, 32:D109-D111.
22. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144.
23. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31:3406-3415.
24. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
25. Nakamura T., Scorilas A., Stephan C., Yousef G.M., Kristiansen G., Jung K., et al. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer 2003, 88:1101-1104.
26. Cheung J., Mak Y.T., Papaioannou S., Evans B.A., Fogelman I., Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: Comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003, 177:423-433.
27. Mazess R.B., Nord R., Hanson J.A., Barden H.S. Bilateral measurement of femoral bone mineral density. J Clin Densitom 2000, 3:133-140.
28. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998, 95:3597-3602.
29. Zhao Q., Wang X., Liu Y., He A., Jia R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 2010, 42:576-579.
30. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-910.
31. Hikata T., Takaishi H., Takito J., Hakozaki A., Furukawa M., Uchikawa S., et al. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood 2009, 113:2202-2212.
32. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 2007, 104:9667-9672.
33. Li H., Xie H., Liu W., Hu R., Huang B., Tan Y.F., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009, 119:3666-3677.
34. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
35. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997, 278:1803-1805.
36. Sonnenblick A., Levy C., Razin E. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol 2004, 24:10584-10592.
37. Levy C., Lee Y.-N., Nechushtan H., Schueler-Furman O., Sonnenblick A., Hacohen S., et al. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. Blood 2006, 107:2839-2845.
38. Jang H.D., Yoon K., Shin Y.J., Kim J., Lee S.Y. PIAS3 suppresses NF-κB-mediated transcription by interacting with the p65/RelA subunit. J Biol Chem 2004, 279:24873-24880.
39. Kim K., Lee J., Kim J.H., Jin H.M., Zhou B., Lee S.Y., et al. Protein inhibitor of activated STAT3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J Immunol 2007, 178:5588-5594.
40. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15:757-765.
41. Guihard P., Danger Y., Brounais B., David E., Brion R., Delecrin J., et al. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 2012, 30:762-772.
42. Henriksen K., Andreassen K.V., Thudium C.S., Gudmann K.N., Moscatelli I., Crüger-Hansen C.E., et al. A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts. Bone 2012, 51:353-361.
43. Dai X.M., Zong X.H., Akhter M.P., Stanley E.R. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res 2004, 19:1441-1451.